 IMATINIB MESYLATE WITH OR WITHOUT INTERFERON ALFA OR CYTARABINE COMPARED WITH INTERFERON ALFA FOLLOWED BY DONOR STEM CELL TRANSPLANT IN TREATING PATIENTS WITH NEWLY DIAGNOSED CHRONIC PHASE CHRONIC MYELOGENOUS LEUKEMIA: 